secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001104659-25-001304
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics appoints Suneel Gupta as EVP, Clinical Development
---------------------------------------------------------------------------

- Effective Jan 1, 2025, Suneel Gupta transitioned from Chief Development Officer to EVP, Clinical Development.
- Gupta, previously CDO, now serves as Executive Vice President, Clinical Development.
- No other officer changes were reported in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/0001104659-25-001304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/tm251959d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-001304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer